Portfolio company
eGenesis
United States · £79.0m raised
Raised
£79.0m
Latest stage
Series B
Rounds recorded
1
Backed by
4 investors
Sectors
About
This company develops genetically engineered pig organs for patients suffering from organ failure and requiring transplantation.
SourceFunding history · 1
Similar companies
LyGenesis
LyGenesis develops regenerative cell therapies that use lymph nodes as bioreactors to grow functioning organs for patients with end-stage organ failure.
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
Satellite Bio
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
Tengion Inc
This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
